Results 221 to 230 of about 38,595 (290)

Comparative Effectiveness of SGLT2i and GLP-1RA on Blood Pressure in Hypertensive Patients with Type 2 Diabetes: A Saudi Multicenter Retrospective Study. [PDF]

J Clin Med
Alshehri G, Alrashidi R, Alhaqbani R, Almeshari R, Bin Sheraim N, Alharbi A, Al Yami MS, Alanazi A, Alsalamah N, Alrossies A.   +9 more
europepmc   +1 more source

Evidence‐Based Clinical Practice Guidelines for Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) 2026

Hepatology Research, Volume 56, Issue 6, Page 887-902, June 2026.
ABSTRACT Metabolic dysfunction‐associated steatotic liver disease (MASLD) has emerged as the most prevalent chronic liver disease worldwide, with an increasing number of patients progressing to cirrhosis and hepatocellular carcinoma (HCC). Early identification of individuals at high risk for advanced fibrosis is essential for preventing liver‐related ...
Norio Akuta, Tomomi Kogiso, Kenichi Ikejima, Motoyuki Otsuka, Takumi Kawaguchi, Miwa Kawanaka, Hirokazu Takahashi, Nobuharu Tamaki, Hayato Nakagawa, Hayato Hikita, Hideki Fujii, Kanji Yamaguchi, Masato Yoneda, Kazuyoshi Kon, Akira Uchiyama, Yuya Seko, Sadatsugu Sakane, Ryuta Shigefuku, Naoto Fujiwara, Michihiro Iwaki, Takashi Kobayashi, Takuya Adachi, Yasuto Takeuchi, Tsubasa Tsutsumi, Dan Nakano, Kaoru Shibayama, Noriyo Urata, Hisamitsu Miyaaki, Hidekatsu Kuroda, Masahiro Koseki, Hirohito Sone, Yasuhiro Matsubayashi, Keisuke Kakisaka, Atsushi Takai, Kazuo Notsumata, Masataka Seike, Yoshiyuki Takei, Yoshifumi Takeyama, Susumu Eguchi, Sumio Watanabe, Hajime Isomoto, Hiroshi Yotsuyanagi, Takao Itoi, Tetsuo Takehara, Satoshi Mochida   +44 more
wiley   +1 more source

Navigating Sarcopenia Risks in GLP-1RA Therapy for Advanced Heart Failure. [PDF]

Biomedicines
Wang W, Green D, Ibrahim R, Abdelnabi M, Pham HN, Forst B, Allam M, Sarkis P, Bcharah G, Farina J, Ayoub C, Sorajja D, Arsanjani R.   +12 more
europepmc   +1 more source

GLP-1RA and aspiration risk in moderate sedation for endoscopy

JCA Advances
Lucia Costanza, Emma B. White, Aadya Chaturvedi, Seungyeop Kang, Courtney A. Chau, Kendrick M. Shaw, Amanda S. Xi   +6 more
openaire   +1 more source

Combining GLP‐1 Receptor Agonists and Health‐Behaviour and Lifestyle Therapy Yields Higher Adherence and Reduces Session Needs for Successful Weight Management in Adolescence: An Observational Real‐World Single‐Center Study

Pediatric Obesity, Volume 21, Issue 6, June 2026.
ABSTRACT Background Evidence for the role of health behaviour and lifestyle treatment (HBLT) on the effectiveness of glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) in paediatric obesity is limited. Objectives To assess the role of HBLT on the effectiveness of GLP‐1RAs in youth with obesity.
Julia Lischka, Gabriel Torbahn, Michael Vallis, Katharina Mörwald, Julian Gomahr, Anders Forslund, Rasmus Stenlid, Hannes Manell, Peter Bergsten, Sabine Geiersberger, Max Bergauer, Lotte Forer, Wanda Lauth, Jeanne Jabbour, Laura Döttl, Maria Swittalek, Stefanie Lanzinger, Daniel Weghuber   +17 more
wiley   +1 more source

Practical recommendations for treating patients with chronic kidney disease in Australia: a multidisciplinary approach

Internal Medicine Journal, Volume 56, Issue 6, Page 966-975, June 2026.
Abstract Background Chronic kidney disease (CKD) is a significant public health challenge in Australia, affecting ~10% of the adult population and contributing to substantial morbidity and mortality. Diabetes, hypertension, cardiovascular disease and CKD frequently co‐exist; therefore, a multidisciplinary approach is necessary to manage these ...
M. P. Schlaich, W. P. Abhayaratna, R. Audehm, E. I. Ekinci, R. J. MacIsaac, A. J. Nelson, A. Sharma, C. Pollock   +7 more
wiley   +1 more source

Identifying High-Risk Obese Individuals Without Diabetes for GLP-1RA Therapy Using Coronary CTA. [PDF]

JACC Adv
Blair CV, Huck D, Besser SA, Cardoso R, Shiyovich A, Berman AN, Biery DW, Weber BN, Petranovic M, Nasir K, Hedgire S, Plutzky J, Cannon C, Di Carli MF, Ghoshhajra BB, Trinquart L, Blankstein R.   +16 more
europepmc   +1 more source

Comparative efficacy and safety of three fixed‐ratio combination products in type 2 diabetes: A network meta‐analysis

Journal of Diabetes Investigation, Volume 17, Issue 6, Page 979-988, June 2026.
Abstract Objective To systematically evaluate and compare the efficacy and safety of three fixed‐ratio combination products—insulin degludec/liraglutide (IDegLira), insulin glargine/lixisenatide (iGlarLixi), and insulin degludec/insulin aspart (IDegAsp)—in patients with type 2 diabetes.
Xiaomei Wang, Jiali Qin, Yang Liu, Xianying Wang   +3 more
wiley   +1 more source

Complete Skin Remission of Lichen Planus With Tirzepatide

Australasian Journal of Dermatology, Volume 67, Issue 4, Page e265-e266, June 2026.
Harmeet Bhullar, Emma Veysey, Tanya Bohl, Saurabh Prakash, Sarah Smithson   +4 more
wiley   +1 more source

Interpretable machine learning models based on CMR radiomics for predicting left ventricular diastolic dysfunction in patients with metabolic‐associated steatotic liver disease and type 2 diabetes mellitus

Journal of Diabetes Investigation, Volume 17, Issue 6, Page 1010-1023, June 2026.
We developed an interpretable machine learning (ML) model combining cardiac magnetic resonance (CMR) radiomics and clinical data to assess left ventricular diastolic dysfunction (LVDD) risk in metabolic‐associated steatotic liver disease (MASLD)/type 2 diabetes mellitus (T2DM) patients, enabling proactive treatment.
Jinying Xia, Shaoyi Leng, Bin Xu, Guang Jin, Jianhui Li, Mingchen Zhang, Danzhen Yao, Ruiting Shen, Qifeng Hua   +8 more
wiley   +1 more source